Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms

• Published in: Frontiers in endocrinology (Lausanne) Vol. 11; p. 125
• Main Authors: Zhou, He, Sun, Lin, Zhang, Siwen, Zhao, Xue, Gang, Xiaokun, Wang, Guixia
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 24.03.2020
• Subjects: Animals; causality; Diabetes Mellitus, Type 1 - etiology; Diabetes Mellitus, Type 1 - pathology; dysbiosis; Dysbiosis - complications; Endocrinology; Gastrointestinal Microbiome - immunology; gut microbiota; Humans; Immune System - immunology; Immune System - microbiology; mechanisms; type 1 diabetes; type 1 diabetes; mechanisms; gut microbiota; causality; dysbiosis
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2020.00125

Type 1 diabetes (T1D) is a multifactorial autoimmune disease mediated by genetic, epigenetic, and environmental factors. In recent years, the emergence of high-throughput sequencing has allowed us to investigate the role of gut microbiota in the development of T1D. Significant changes in the composition of gut microbiome, also termed dysbiosis, have been found in subjects with clinical or preclinical T1D. However, whether the dysbiosis is a cause or an effect of the disease remains unclear. Currently, increasing evidence has supported a causal link between intestine microflora and T1D development. The current review will focus on recent research regarding the associations between intestine microbiome and T1D progression with an intention to evaluate the causality. We will also discuss the possible mechanisms by which imbalanced gut microbiota leads to the development of T1D.